Effects of Atomoxetine Treatment in Humans

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

September 30, 2009

Conditions
Stress
Interventions
DRUG

Placebo

Placebo

DRUG

Atomoxetine

20mg maximum of d-amphetamine

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

Yale University

OTHER

NCT00611936 - Effects of Atomoxetine Treatment in Humans | Biotech Hunter | Biotech Hunter